JENNIFER MURY: Open Payments
NPI 1427399856 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 32 payments from 10 companies in 2025. Trend: 2023 $595 · 2024 $560 · 2025 $592
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 11 | $274 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $103 |
| Evofem Biosciences, Inc. | 5 | $64 |
| Exeltis, USA Inc. | 2 | $31 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Organon LLC | 1 | $22 |
| Ethicon US, LLC | 1 | $20 |
| Dexcom, Inc. | 1 | $20 |
| MILLICENT US INC | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
Products named: ZURZUVAE, Phexxi, SLYND, APTIMA, NEXPLANON, ETHICON, Dexcom G6 Transmitter, FEMRING.
Industry payments across TX — which companies pay providers there.
